Are there any residual effects after involution of a scalp hemangioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Residual Effects After Involution of Scalp Hemangiomas

Yes, residual skin changes frequently occur after involution of scalp hemangiomas, with approximately 50-70% of infantile hemangiomas leaving behind telangiectasias, fibrofatty tissue, redundant skin, atrophy, dyspigmentation, or scarring. 1, 2

Natural History and Involution Timeline

Infantile hemangiomas follow a predictable life cycle:

  • Most appear by 4 weeks of age
  • Rapid growth occurs between 5-7 weeks of age
  • 80% of growth is completed by 3 months
  • Growth typically stops by 5-12 months of age
  • Involution begins between 6-12 months, appearing as color change from red to milky-white/gray
  • 90% of involution is complete by 4 years of age 1, 2

Common Residual Effects

After involution, the following residual changes may persist:

  1. Telangiectasias - dilated superficial blood vessels
  2. Fibrofatty tissue - residual bulk or contour deformity
  3. Redundant skin - excess loose skin
  4. Atrophy - thinning of the skin
  5. Dyspigmentation - color changes in the skin
  6. Scarring - particularly in areas that previously ulcerated 1

Factors Influencing Residual Changes

The likelihood and severity of residual changes depend on:

  • Size and depth of the original hemangioma
  • Location on the scalp
  • Complications during growth phase (ulceration, bleeding)
  • Prior treatments received 2

Management of Residual Changes

By 4 years of age, it's usually possible to determine whether residual changes will persist and require intervention 1. Management options include:

1. Laser Therapy

  • Pulsed dye laser (PDL) is highly effective for residual telangiectasias and flat areas
  • Potential complications include atrophic scarring and hypopigmentation, particularly in darker skin types 1

2. Surgical Management

  • Indicated for significant fibrofatty residuum or redundant skin
  • Optimal timing is typically around 3-4 years of age, before the child develops significant self-awareness but after maximum involution has occurred
  • Surgical approaches include:
    • Elliptical excision with primary closure
    • Rotational flap closure for larger defects
    • Partial resection with natural contour restoration 1, 3, 4

3. Observation

  • Appropriate for minor residual changes that don't cause functional or significant cosmetic concerns

Decision-Making Algorithm for Residual Changes

  1. Assess at age 4 years when 90% of involution is complete
  2. Evaluate residual changes:
    • Minimal changes → observation
    • Telangiectasias only → consider PDL
    • Significant fibrofatty tissue or redundant skin → consider surgical correction
  3. Consider impact on quality of life:
    • Functional impairment
    • Psychological impact (especially before school entry)
    • Location visibility
  4. Consult appropriate specialist:
    • Dermatologist for laser therapy
    • Plastic surgeon or dermatologic surgeon for excision

Important Considerations

  • Surgical correction of residual changes often yields excellent cosmetic outcomes when performed by experienced surgeons 3, 4
  • For scalp hemangiomas specifically, alopecia is a common residual finding that may require surgical correction 4
  • Suture lines should be placed along natural skin lines or anatomical borders for optimal cosmetic results 3
  • Early intervention during the proliferative phase (with propranolol or other treatments) may reduce the likelihood of significant residual changes 1

By understanding the natural history and potential residual effects of scalp hemangiomas, clinicians can provide appropriate guidance to parents and make timely referrals for intervention when necessary.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Infantile Hemangiomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surgical Management of Scalp Infantile Hemangiomas.

The Journal of craniofacial surgery, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.